Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Aptorum Group Ltd
APM
Healthcare
Biotechnology
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small...
molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The company also develops SACT-COV19, a repurposed small molecule which is in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule which is in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resist...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:APM)
New Post
View:
Posts & Comments
Threaded Posts
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 31, 2024 10:33am
Using technical analysis for this stock.
You guys should have been buying this one this morning.
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 14, 2024 12:07pm
APM.....my timing was perfect
And not 1 like....u sure are a tough audience !!!!
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 14, 2024 11:44am
RE:APM ...possible pivot here
Excellent handicapping Iseneschal ; ) Cha f'king Ching !!!!!! sold to america !!!!!!!!!!!!!!
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 14, 2024 11:36am
APM ...possible pivot here
needs a break of $7.40 ....then $7.70
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 14, 2024 11:33am
APM....Volumes are increasing on the 5 min candles
just an observation ....now at $7.30
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 14, 2024 10:26am
RE:APM ...$10 Holla ?
$5 Holla...for sure ; )
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 14, 2024 9:50am
APM ...$10 Holla ?
Maybe
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 14, 2024 8:50am
RE:APM.....still on watch after the last run
$7.25 now....on over 700K shs
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 14, 2024 8:48am
APM.....still on watch after the last run
Up 50% on no news .....last at $6.30 on 440,000 shs No positon
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 06, 2024 11:54am
APM ....Sold to America!!!!
What a fluke..... 100 shs bot this a.m Didn't even look at it until it was Halted for the 3rd time....LoL Call me lucky!
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 06, 2024 11:42am
RE:APM .... early a.m runner on NR
I'm rich !!!! N.H.O.D !!!!!!
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 06, 2024 9:17am
APM .... early a.m runner on NR
On watch
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on May 03, 2023 2:17pm
APM .... The Chaser are screwed...down 50 % from the top
It's a harsh world
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on May 03, 2023 9:15am
APM...early a.m runner up large
On watch
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines
Team spotlight: Q+A: Charlene Duffett, Viridian Metals exploration manager
Eshbal quickly expanding commercial and consumer footprint for gluten-free and health food brands
Freegold Ventures reports results from six additional drill holes at its Golden Summit project
Podcasts